Ethical issues in multiple sclerosis

Seminars in Neurology

Volumn 17, Issue 3, 1997, Pages 227-234

  Nelson, Robert F ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Assisted suicide; Confidentiality; Disclosure; Drug trials; End of life issues; Multiple sclerosis; Pregnancy

Indexed keywords

CONFIDENTIALITY; DOCTOR PATIENT RELATION; DRIVING ABILITY; MEDICAL DECISION MAKING; MEDICAL ETHICS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTION; REVIEW; SUICIDE; TREATMENT PLANNING;

EID: 0030882285     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040933     Document Type: Review

References (21)

1. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31
2. Elian M, Dean G. To tell or not to tell the diagnosis of multiple sclerosis. Lancet 1985;2:27-8
3. Burnfield A. Doctor-patient dilemmas in multiple sclerosis. J Med Ethics 1984;1:21-6
4. Robinson I. The context and consequences of communicating the diagnosis of multiple sclerosis. In Weitholder H, Dichgans J, Mertin J, eds. Current concepts in multiple sclerosis. Amsterdam: Elsevier, 1990;17-22
5. Teasdale K, Kent G. The use of deception in nursing. J Med Ethics 1995;21:77-81
6. Van den Noort S. Ethical aspects of unproven therapies in multiple sclerosis, amyotrophic lateral sclerosis, and other neurological diseases. Semin Neurol 1984;4:83-6
7. Mitchel JN. Multiple sclerosis and the prospects for employment. J Soc Occup Med 1981;31:134-8
8. Runmarker B, Andersen O. Pregnancy is associated with a lower risk at onset and a better prognosis in multiple sclerosis. Brain 1995;118:252-61
9. Sadovnik AD, Kathleen E, Hashimoto SA, et al. Pregnancy and multiple sclerosis: a prospective study Arch Neurol 1994;51: 1120-4
10. Sadovnik AD. Familial recurrence risks and inheritance of multiple sclerosis. Curr Opin Neurol Neurosurg 1993;6:189-94
11. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-46
12. McGuiness S. Learned helplessness in the multiple sclerosis population. J Neurosci Nursing 1996;28:163-74
13. Crigger NJ. Testing an uncertainty model for women with multiple sclerosis. Adv Nursing Sci 1996;18:37-47
14. Stewart DC, Sullivan TJ. The illness behaviour and the sick role in chronic disease; the case of multiple sclerosis. Soc Sci Med 1982;16:1397-404
15. Cella DF, Dinneen MA, Arnason B, et al. Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument. Neurology 1996;47:129-39
16. MacIntosh-Michaelis SA, Roberts MH, Wilkinson SM, et al. The prevalence of cognitive impairment in a community survey of multiple sclerosis. BrJ Clin Psychol 1991;30:333-48
17. Feinstein A. Neuropsychological dysfunction in multiple sclerosis. Int MSJ 1995;2:61-7
18. National Multiple Sclerosis Society [USA]. Clinical trials of new agents in multiple sclerosis planned, in progress, recently completed. April 1996
19. Mohr DC, Neilley L, Gatto N, et al. Expectations of multiple sclerosis patients initiating Betaseron therapy. Neurology 1995; 45(suppl 4):197
20. Goodkin DE, Kanoti GA. Ethical considerations raised by the approval of interferon beta-1b for the treatment of multiple sclerosis. Neurology 1994;44:166-70
21. Boston Sunday Globe, August 26, 1996